uniQure N.V. - Ordinary Shares (QURE) Social Stream
uniQure NV (QURE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering uniQure NV.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 15 | $95 | $40 | $67.916 | $20.45 | 232.11% |
| 2021-12-10 | 14 | $95 | $40 | $68 | $20.45 | 232.52% |
| 2021-12-17 | 14 | $95 | $40 | $66.416 | $20.45 | 224.77% |
| 2022-03-01 | 13 | $95 | $40 | $66.363 | $20.45 | 224.51% |
| 2022-03-17 | 13 | $95 | $40 | $66.363 | $20.45 | 224.51% |
| 2022-03-29 | 13 | $95.001 | $40 | $66.363 | $20.45 | 224.51% |
| 2022-03-30 | 13 | $90 | $40 | $64.8 | $20.45 | 216.87% |
The Trend in the Analyst Price Target
QURE's average price target has moved down $22.05 over the prior 22 months.
Over the past 50 weeks, QURE's average upside potential has been 161.51%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-05 | 17 | 100.000 | 40 | 68.530 | 35.32 | 94.03% |
| 2021-06-21 | 18 | 100.000 | 40 | 67.290 | 32.84 | 104.9% |
| 2021-07-03 | 18 | 100.000 | 40 | 67.570 | 30.50 | 121.54% |
| 2021-08-07 | 18 | 95.000 | 40 | 66.970 | 30.52 | 119.43% |
| 2022-03-29 | 13 | 95.001 | 40 | 66.363 | 17.80 | 272.83% |
QURE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.08 | 12 | 1 | 0 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
QURE's average broker recommendation rating improved by 0.05 over the prior 120 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- QURE has a greater upside potential (average analyst target price relative to current price) than 810.56% of all US stocks.
- uniQure NV's number of analysts covering the stock is greater than 862.04% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, uniQure NV's variance in analysts' estimates is lower than -676.89% of them.
- In the context of Pharmaceutical Products stocks, uniQure NV's average analyst price target is greater than 700.91% of them.
Stocks similar to uniQure NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PTGX, PTCT, and PRTA.
Is QURE a Buy, Hold or Sell? See the POWR Ratings now!